Detalles de la búsqueda
1.
Phase I dose escalation study of BI 836826 (CD37 antibody) in patients with relapsed or refractory B-cell non-Hodgkin lymphoma.
Invest New Drugs
; 38(5): 1472-1482, 2020 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-32172489
2.
A phase I/II multicenter, open-label, dose escalation and randomized trial of BI 836858 in patients with low- or intermediate-1-risk myelodysplastic syndrome.
Haematologica
; 107(11): 2742-2747, 2022 11 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35734924
3.
A phase I study of the fully human, fragment crystallizable-engineered, anti-CD-33 monoclonal antibody BI 836858 in patients with previously-treated acute myeloid leukemia.
Haematologica
; 107(3): 770-773, 2022 03 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34854276
4.
An open-label, phase I/II trial to determine the maximum tolerated dose and investigate safety, pharmacokinetics and efficacy of BI 836858, an unconjugated anti-CD33 monoclonal antibody, in combination with decitabine in patients with acute myeloid leukemia.
Haematologica
; 107(12): 2977-2982, 2022 12 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36005556
5.
Correction to: Phase I dose escalation study of BI 836826 (CD37 antibody) in patients with relapsed or refractory B-cell non-Hodgkin lymphoma.
Invest New Drugs
; 39(1): 283-284, 2021 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-32474843
6.
Correction to: Phase I dose escalation study of BI 836826 (CD37 antibody) in patients with relapsed or refractory B cell non-Hodgkin lymphoma.
Invest New Drugs
; 39(1): 285-286, 2021 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-32578153
7.
The Absolute Bioavailability, Absorption, Distribution, Metabolism, and Excretion of BI 425809 Administered as an Oral Dose or an Oral Dose with an Intravenous Microtracer Dose of [14C]-BI 425809 in Healthy Males.
Clin Drug Investig
; 42(1): 87-99, 2022 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-34936055
8.
Correction to: The Absolute Bioavailability, Absorption, Distribution, Metabolism, and Excretion of BI 425809 Administered as an Oral Dose or an Oral Dose with an Intravenous Microtracer Dose of [14C]BI 425809 in Healthy Males.
Clin Drug Investig
; 42(4): 375, 2022 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-35286627
Resultados
1 -
8
de 8
1
Próxima >
>>